Latest News and Press Releases

LEIDEN, Netherlands, July 15, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that they have...

LEIDEN, Netherlands, July 14, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced plans for the clinical development of its combination of two...

LEIDEN, Netherlands, July 13, 2005 (PRIMEZONE) -- Euronext.liffe today announced that options for Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) are to be listed on...

LEIDEN, Netherlands, July 5, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Nasdaq:CRXL) (Euronext:CRXL) today announced that it will release its financial results for the second...

LEIDEN, Netherlands, June 28, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that Fidelity's FID Growth Company Fund has acquired a 5.13%...

LEIDEN, Netherlands, June 10, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announces the discovery of a monoclonal antibody for protection against...

LEIDEN, Netherlands, June 1, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has started an evaluation program with Medarex, Inc.,...

LEIDEN, Netherlands, May 31, 2005 (PRIMEZONE) -- Options for Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) have been listed on the Chicago Board Options Exchange (CBOE), the...

LEIDEN, Netherlands, May 25, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that they have...

LEIDEN, Netherlands, May 20, 2005 (PRIMEZONE) -- Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) has announced that its Chief Financial Officer, Leonard Kruimer, will present at the Annual Needham &...